concept referred imprinting phenomenon not completely understood current science strongly suggests years later exposed flu virus vaccine tend skew response original type influenza got exposed fauci notes result strongest immune system defense flu strain encountered clinical trials regulatory hurdles vast array technical roadblocks ahead include making shots profitable developers affordable consumers deciding receive inoculations far not clear runner vaccine multiple candidates earlier month national institutes health announced experimental vaccine m-001 headed phase ii clinical trials investigators monitor safety adults assess appears help mount clear defense flu virus vaccine slated enter trials europe older adults population differs u.s. test subjects healthy